Advances in psychopharmacology--schizophrenia.
نویسنده
چکیده
Every so often in the history of medicine, events occur which in retrospect seem to mark a defining moment. For psychiatry, the decade of the 1950s uses one such 'moment.' On 28 December 1951, J. Sigwald started solo chlorpromazine treatment of a 57-year-old psychotic lady and, thereby, it might be argued, began the modern era of psychopharmacology.
منابع مشابه
Current issues in child and adolescent psychopharmacology. Part 2: Anxiety and obsessive–compulsive disorders, autism, Tourette’s and schizophrenia
Part 1 of this two-part consideration of child and adolescent psychopharmacology focused on attention–deficit hyperactivity disorder (ADHD), depression and bipolar disorder (Coghill, 2003). This second paper concentrates on current pharmacological approaches to the treatment of anxiety disorders, obsessive–compulsive disorders, autism, Tourette syndrome and schizophrenia. The aim is to describe...
متن کاملPositron emission tomography studies of abnormal glucose metabolism in schizophrenia.
Schizophrenia, a devastating disease characterized by a combination of various types of disturbed behaviors, thoughts, and feelings, may likewise be heterogeneous in etiology. Recent advances in neuroscience and psychopharmacology have suggested a wide array of competing mechanisms that may be involved in schizophrenia, including but not limited to deficits in one or more neurotransmitters and ...
متن کاملWhen the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity
Treatment-resistant schizophrenia is a serious clinical problem. We adopt a systems-level approach positing a greater role for cognitive control mechanisms in the development of psychotic symptoms and illustrate the clinical application of this via a case report of treatment-resistant patients treated successfully with adjunct pro-cognitive serotonergic medication.
متن کاملDeterminants of medication compliance in schizophrenia: empirical and clinical findings.
Advances in psychopharmacology have produced medications with substantial efficacy in the treatment of positive and negative symptoms of schizophrenia and the prevention of relapse or symptom exacerbation after an acute episode. In the clinical setting, the individual patient's acceptance or rejection of prescribed pharmacological regimens is often the single greatest determinant of these treat...
متن کاملStatistical Sleuthing During Epidemics: Maternal Influenza and Schizophrenia
Schizophrenia is among the most debilitating of mental illnesses (NARSAD 2003). Although relatively rare, affecting less than 1% of the population, this form of psychosis is the focus of a great deal of study due to its etiological complexity and its devastating social, economic, and personal effects. The National Institute of Mental Health estimates that schizophrenia is responsible for 2.3 mi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British medical bulletin
دوره 52 3 شماره
صفحات -
تاریخ انتشار 1996